Myocarditis post infection is an inflammation of the heart muscle that typically develops after a viral or other infection. Understanding how to diagnose this condition properly is essential, as early detection can help prevent serious complications and guide appropriate treatment decisions.

Introduction: Who Should Undergo Diagnostics

Diagnosing myocarditis following an infection requires careful attention to symptoms and timely medical evaluation. Many people who develop this condition may not immediately recognize that their heart is affected, especially since the symptoms can be subtle or mirror those of other illnesses. Anyone who experiences chest pain, unusual fatigue, shortness of breath, or irregular heartbeats after recovering from a viral infection should seek medical attention promptly.^[1]

The challenge with post-infection myocarditis is that some individuals may have no symptoms at all, while others experience severe problems that develop rapidly. Because of this wide range of presentations, it is particularly important for people who have recently had a viral illness to be aware of new or worsening symptoms related to their heart. Young adults and males appear to be more commonly affected, though the condition can occur in anyone regardless of age or gender.^[5]

If you notice persistent chest discomfort, especially when combined with difficulty breathing during normal activities or when lying down, this warrants immediate medical evaluation. Similarly, if you experience episodes where your heart feels like it is racing or beating irregularly, or if you feel lightheaded or faint without an obvious cause, these signs should not be ignored. Parents should be particularly vigilant with children who may show less specific symptoms such as irritability, poor feeding, rapid breathing, or unusual lethargy following an illness.^[1]

People with certain medical conditions or recent medical procedures may also need to be more aware of the possibility of myocarditis. Those with autoimmune diseases, individuals who have undergone specific medical treatments such as radiation therapy, or people taking certain medications should discuss with their healthcare provider whether additional monitoring for heart inflammation might be appropriate after an infection.^[5]

Diagnostic Methods for Identifying Myocarditis

When a healthcare provider suspects myocarditis following an infection, the diagnostic process typically begins with a thorough physical examination. During this initial assessment, your doctor will listen to your heart with a stethoscope, checking for abnormal sounds or rhythms that might indicate heart muscle inflammation. They will also ask detailed questions about your recent medical history, including any viral infections, symptoms you’ve experienced, and how long these symptoms have been present.^[6]

Blood tests form a crucial part of the diagnostic evaluation for myocarditis. These tests can detect markers of heart muscle damage and inflammation in your bloodstream. One key test measures cardiac enzymes, which are proteins released when heart muscle cells are damaged. Elevated levels of these proteins suggest that the heart muscle may be injured. Blood tests can also look for signs of infection and measure antibodies that indicate whether your body has recently fought off a viral illness. Additionally, these tests check for markers of inflammation throughout the body, such as C-reactive protein and erythrocyte sedimentation rate, which help confirm that an inflammatory process is occurring.^[6][7]

An electrocardiogram, commonly known as an ECG or EKG, is a quick and painless test that records the electrical activity of your heart. During this test, small electrodes are attached to your chest, arms, and legs to detect the electrical signals that control your heartbeat. The patterns seen on an ECG can reveal irregular heart rhythms, areas of the heart that may be damaged, or other electrical abnormalities associated with myocarditis. While this test cannot definitively diagnose myocarditis on its own, abnormal findings can provide important clues that guide further testing.^[6]

A chest X-ray offers a simple way to examine the size and shape of your heart and lungs. This imaging test can show if your heart has become enlarged, which sometimes occurs when myocarditis weakens the heart muscle and forces it to work harder. The X-ray can also detect fluid accumulation in or around the heart, which may be related to heart failure, a potential complication of myocarditis.^[6]

An echocardiogram uses sound waves to create moving pictures of your beating heart. This non-invasive test allows doctors to see the heart’s structure and watch how blood flows through its chambers and valves. The echocardiogram can reveal if the heart muscle is pumping effectively or if it has weakened due to inflammation. It can also detect fluid accumulation around the heart and assess the heart’s overall function. This test is particularly valuable because it provides real-time information about how well your heart is working.^[6]

Cardiac magnetic resonance imaging, or cardiac MRI, is considered one of the most valuable imaging tests for diagnosing myocarditis. This sophisticated test uses powerful magnets and radio waves to create detailed images of the heart’s structure and tissue. Unlike other imaging methods, cardiac MRI can directly visualize inflammation and scarring in the heart muscle, making it especially useful for confirming myocarditis and determining its severity. The test can show areas of the heart that are inflamed or damaged, helping doctors make more informed treatment decisions.^[6][7]

In cases where the diagnosis remains uncertain despite these non-invasive tests, doctors may recommend an endomyocardial biopsy. This procedure is considered the gold standard for definitively diagnosing myocarditis. During this test, a doctor inserts a thin, flexible tube called a catheter into a blood vessel, usually in the arm or groin, and carefully guides it to the heart. A tiny tissue sample is then removed from the heart muscle and examined under a microscope. The biopsy can confirm inflammation, identify the specific type of myocarditis, and sometimes help determine what caused it. However, because this is an invasive procedure with some risks, it is typically reserved for patients with severe symptoms, those whose condition is worsening despite treatment, or those who may need specific therapies based on the type of myocarditis identified.^[6][7]

Your healthcare provider may also order tests to identify the specific infection that triggered the myocarditis. These might include blood tests to detect particular viruses such as parvovirus B-19, human herpesvirus 6, Epstein-Barr virus, or SARS-CoV-2 (the virus that causes COVID-19). In some cases, doctors may test samples from the throat, stool, or other body fluids to identify viral or bacterial pathogens. Understanding which infection caused the myocarditis can sometimes influence treatment decisions, although in many cases the specific infectious agent remains unknown.^[3][7]

Because myocarditis symptoms can resemble those of other heart conditions, particularly heart attacks, an important part of the diagnostic process involves ruling out alternative explanations for your symptoms. Your doctor may perform cardiac catheterization to examine the blood vessels supplying your heart, ensuring that blocked arteries are not causing your symptoms. They may also consult with specialists in infectious diseases or rheumatology to help evaluate whether other conditions, such as autoimmune disorders, might be contributing to your symptoms.^[6]

Diagnostics for Clinical Trial Qualification

When patients with post-infection myocarditis are being considered for enrollment in clinical trials, specific diagnostic criteria must typically be met to ensure that participants truly have the condition being studied and that the trial can safely include them. Clinical trials investigating myocarditis treatments or outcomes generally require thorough documentation of the diagnosis through a combination of clinical presentation, biomarker evidence, and imaging findings.^[7]

Most clinical trials require confirmation of myocarditis through established diagnostic criteria. This often means documenting specific symptoms consistent with myocarditis, such as chest pain, shortness of breath, or heart rhythm abnormalities, along with objective evidence from diagnostic tests. Elevated cardiac biomarkers, particularly troponin levels that indicate heart muscle damage, are frequently required as part of the enrollment criteria. These biomarkers provide measurable evidence that heart muscle injury has occurred.^[7]

Cardiac MRI findings play a particularly important role in clinical trial qualification for myocarditis studies. Many trials require that patients show characteristic patterns of inflammation or injury on cardiac MRI that are consistent with myocarditis. These imaging findings help ensure that trial participants have genuine myocarditis rather than other heart conditions that might produce similar symptoms. The MRI can also provide baseline information about the extent of heart muscle damage, which researchers can use to track whether treatments are effective over time.^[7]

Some clinical trials may require confirmation of recent infection, particularly if the study is investigating myocarditis that develops after specific viral illnesses. This might involve documenting a recent positive test for viruses such as SARS-CoV-2, influenza, or other pathogens known to trigger myocarditis. In certain trials, particularly those studying giant cell myocarditis or other specific subtypes, an endomyocardial biopsy may be required to confirm the diagnosis and classify the type of inflammation present.^[3]

Clinical trials also typically assess the functional status of your heart through tests like echocardiography, which measures the heart’s pumping ability. The ejection fraction, which represents the percentage of blood pumped out of the heart with each beat, is often used as an enrollment criterion. Some trials may focus on patients with reduced ejection fraction, while others may include patients across a range of heart function levels. These measurements help researchers understand how severely the heart has been affected and whether treatments improve its function.^[6]

Trial protocols often specify that participants undergo baseline electrocardiogram testing to document any electrical abnormalities of the heart. This provides a reference point for monitoring changes during the study and helps identify patients who might be at higher risk for serious heart rhythm problems. Blood tests beyond basic cardiac markers may also be required, including comprehensive panels that check liver and kidney function, blood cell counts, and inflammatory markers. These tests ensure that participants are healthy enough to safely receive the treatments being studied and help researchers identify any changes that occur during the trial.^[6]